Organic & Biomolecular Chemistry
Page 6 of 7
transferred into the yeast mannan coated plates, incubated 1 h at
found 3577.0631.
37 °C. The washing step was repeated and 50 ꢃL/well ABTS 60 Synthesis of compound 7: Compound 6 (711 mg, 0.2 mM) was
(0.25 mg/ml citrate buffer 0.2 M, pH = 4.0 with 0.015 % (v/v)
H2O2) were added. Color development was stopped after 20 min
by adding 50 ꢃL/well 1M H2SO4. Light absorption was measured
at 415 nm.
dissolved in MeOH (20 mL), a solution of sodium hydroxide (2.0
mL, 8 mM in H2O) was added, and the reaction mixture was
stirred at room temperature until disappearance of the starting
material. The mixture was neutralized with dilute hydrochloric
65 acid (2 M). And the solid was filtered, washed with MeOH. Then
the solid was dissolved in water, the solution was put in a
cellulose dialysis tube (cutoff 1000), dialyzed against water for 2
d, and lyophilized to give the desired solid polymer. 7 (458 mg)
was obtained with yield of 90 %. m. p. 143.8ꢀ145.4 ºC; FT–IR
5
% Inhibition = (A(no inhibitor) ꢀ A(with inhibitor) )/A(no inhibitor) ×100
Synthesis of compound 2: Compound 1 (2.0 g, 3.77 mM) and
propargylamine (0.72 mL, 11.3 mM) were mixed in isoꢀpropyl
10 alcohol (100 mL). The reaction mixture was refluxing under N2
for 24 h. After cooling to room temperature, the reaction mixture
was poured into ice water, the solid compound was filtered,
washed by water. The residue was purified by silicaꢀgel column
chromatography using CH2Cl2/petroleum ether (v/v = 1.5/1) as
15 the eluent to give the product as a red powder (1.2 g) at yield of
52.8 %. m. p. > 250°C. 1H NMR (600 MHz, CDCl3, ppm): δ 2.24
(t, J = 1.8 Hz, 2H, ꢀC≡CH), 4.99 (s, 4H, ꢀCH2ꢀ), 8.73 (s, 4H,
peryleneꢀH); 13C NMR (150 MHz, CDCl3, ppm): δ 29.6, 71.2,
122.9, 123.3, 128.8, 133.2, 135.5, 161.4. HRMS: calcd for
20 C30H10Cl4N2O4, 603.9365; found 603.9371.
1
70 (KBr) v [cm–1]: 1697, 1658, 1589, 1500; H NMR (600 MHz,
DMSOꢀd6, ppm): δ 3.17 (m, 6H), 3.34ꢀ3.42 (m, 12H), 3.56 (m,
6H), 3.63 (d, J = 10.8 Hz, 4H), 3.75 (m, 2H), 3.82 (m, 4H), 3.89
(m, 2H), 3.97 (s, 4H), 4.44ꢀ4.81 (m, 25H), 5.13 (s, 8H), 5.23 (s,
4H), 7.02ꢀ7.08 (m, 16H, ArꢀH), 7.86 (s, 4H, Triaz1ꢀH); 7.99 (s,
75 2H, Triaz2ꢀH); 8.22 (s, 4H, peryleneꢀH); 13C NMR (100 MHz,
DMSOꢀd6, ppm): δ 49.9, 61.4, 61.9, 65.3, 67.0, 70.3, 71.0, 74.4,
100.2, 116.5, 118.3, 118.9, 119.3, 121.8, 122.5, 124.1, 125.4,
132.6, 142.9, 148.6, 155.6, 156.4, 162.7; HRMS: calcd for
C114H128N20O48Na+, 2568.8121; found 2568.8109.
Synthesis of compound 4: Compound 2 (500 mg, 0.8 mM),
K2CO3 (913 mg, 6.6 mM) and compound 3 (735 mg, 5.0 mM)
were mixed in NMP (40 mL). The reaction mixture was heated at
90 °C for 12 h. After cooling to room temperature, the reaction
25 mixture was poured into hydrochloric acid solution, the solid
compound was filtered, washed by water. The residue was
purified by silicaꢀgel column chromatography using
CH2Cl2/petroleum ether (v/v = 10/1) as the eluent to give the
product as a red powder (350 mg) at yield of 40.2 %. m. p. 233.4ꢀ
30 235.6 °C. 1H NMR (600 MHz, CDCl3, ppm): δ 2.15 (t, J = 1.8 Hz,
2H, ꢀC≡CH); 2.57 (t, J = 1.8 Hz, 4H, ꢀC≡CH); 4.67 (d, J = 2.4
Hz, 8H, ꢀOCH2ꢀ); 4.88 (d, J = 1.8 Hz, 4H, ꢀNCH2ꢀ); 6.90 (s, 16H,
ArꢀH); 8.17 (s, 4H, peryleneꢀH); 13C NMR 150 MHz, CDCl3,
ppm): δ 29.7, 56.3, 70.6, 75.8, 78.3, 78.3, 116.4, 119.2, 119.4,
35 120.2, 121.2, 122.1, 132.9, 149.1, 154.6, 156.4, 162.5. HRMS:
calcd for C66H38N2O12, 1050.2425; found 1050.2435.
80 Acknowledgements
We thank NSFC (21002020), Hebei Natural Science Foundation
(B2011201052, B2012201041) and the Foundation of Hebei
Education Department (2010106) for financial support.
References
1
(a) D. H. Dube, C. R. Bertozzi, Nat. Rev. Drug Discovery, 2005, 4,
477; (b) Z. Shriver, S. Raguram, R. Sasisekharan, Nat. Rev. Drug
Discovery, 2004, 3, 863; (c) P. M. Rudd, T. Elliott, P. Cresswell, I. A.
Wilson, R. A. Dwek, Science, 2001, 291, 2370; (d) R. Raman, S.
Raguram, G. Venkataraman, J. C. Paulson, R. Sasisekharan, Nat.
Methods, 2005, 2, 817; (e) M. M. Fuster, J. D. Esko, Nat. Rev.
Cancer, 2005, 5, 526; (f) F. T. Liu, G. A. Rabinovich, Nat. Rev.
Cancer, 2005, 5, 29; (g) C. M. Szymanski, B. W. Wren, Nat. Rev.
Microbiol., 2005, 3, 225; (h) K. Ohtsubo, J. D. Marth, Cell, 2006, 126,
855; (i) P. R. Crocker, J. C. Paulson, A. Varki, Nat. Rev. Immunol.,
2007, 7, 255; (j) P. Niederhafner, M. Reiniš, J. Šebestík, J. Ježek, J.
Pept. Sci., 2008, 14, 556.
Synthesis of compound 6: Compound 4 (300 mg, 0.28 mmol)
and compound 5 (254 mg, 2.02 mM) were dissolved in THF (50
mL), and the water solution of CuSO4ꢂ5H2O (38 mg, 0.51 mM)
40 and sodium ascorbate (50 mg, 0.84 mM) were added, respectively.
The mixture was stirred for 10 h at 55 °C. The solvent was
evaporated under vacuum. The residue was purified by silicaꢀgel
column chromatography using CH2Cl2/CH3OH (v/v = 30/1) as the
eluent to give the product as a dark red solid (460 mg) at yield of
45 63.3 %. m. p. 108.1ꢀ109.8 °C; FT–IR (KBr) v [cm–1]: 1749, 1699,
2
(a) T. C. Shiao, R. Roy, New J. Chem., 2012, 36, 324; (b) M. Touaibia,
R. Roy, MiniꢀRev. Med. Chem., 2007, 7, 1270; (c) R. J. Pieters, Med.
Res. Rev., 2007, 27, 796; (d) M. Hartmann, T. K. Lindhorst, Eur. J.
Org. Chem., 2011, 3583; (e) S. Jin, Y. Cheng, S. Reid, M. Li, B.
Wang, Med. Res. Rev., 2010, 30, 171.
3
4
(a) J. J. Lundquist, E. J. Toone, Chem. Rev., 2002, 102, 555; (b) M.
Mammen, S. K. Choi, G. M. Whitesides, Angew. Chem. Int. Ed., 1998,
37, 2754.
(a) A. Dondoni, Chem. Asian J., 2007, 2, 700; (b) D. Deniaud, K.
Julienne, S. G. Gouin, Org. Biomol. Chem., 2011, 9, 966; (c) O.
Renaudet, MiniꢀReview. Org. Chem., 2008, 5, 274 ; (d) A. Dondoni,
A. Marra, Chem. Rev., 2010, 110, 4949; (e) C. O. Mellet, J. Defaye, J.
M. G. Fernádez, Chem. Eur. J., 2002, 8, 1982.
1
1662, 1589, 1500; H NMR (600 MHz, CDCl3, ppm): δ 1.92 (s,
6H, ꢀCOCH3), 1.98 (s, 12H, ꢀCOCH3), 2.01 (s, 18H, ꢀCOCH3),
2.05 (s, 6H, ꢀCOCH3), 2.09 (s, 18H, ꢀCOCH3), 2.13 (s, 12H, ꢀ
COCH3), 3.52ꢀ3.57 (m, 6H), 3.82 (m, 2H), 3.92 (m, 4H), 3.98 (d,
50 J = 12.6 Hz, 2H), 4.03ꢀ4.07 (m, 6H), 4.13ꢀ4.22 (m, 10H), 4.50 (t,
J = 4.8 Hz, 4H), 4.65 (t, J = 5.4 Hz, 8H), 4.74 (s, 2H), 4.81 (s,
4H), 5.13 (s, 2H), 5.19ꢀ5.24 (m, 24H), 5.40ꢀ5.45 (m, 4H), 6.90
(dd, J = 10.8 Hz, 19.8 Hz, 16H, ArꢀH); 7.69 (s, 2H, ꢀTriaz1ꢀH);
7.80 (s, 4H, Triaz2ꢀH); 8.08 (s, 4H, peryleneꢀH); 13C NMR (150
55 MHz, CDCl3, ppm): δ 20.5, 20.6, 20.6, 20.7, 49.8, 62.2, 65.8,
66.2, 68.8, 69.1, 69.2, 97.5, 116.3, 119.3, 120.1, 121.4, 122.3,
124.0, 132.8, 144.1, 149.0, 155.3, 156.4, 162.9, 169.5, 169.8,
169.8, 170.4; HRMS: calcd for C162H176N20O72Na+, 3577.0657;
5
6
(a) A. VargasꢀBerenguel, F. OrtegaꢀCaballero, J. M. CasasꢀSolvas,
MiniꢀRev. Org. Chem., 2007, 4, 1; (b) R. J. Pieters, Org. Biomol.
Chem., 2009, 7, 2013; (c) Y. Lim, M. Lee, Org. Biomol. Chem.,
2007, 5, 401; (d) K. Li, B. Liu, Polym. Chem., 2010, 1, 252; (e) N.
Jayaraman, Chem. Soc. Rev., 2009, 38, 3463.
(a) M. K. Müller, L. Brunsveld, Angew. Chem. Int. Ed., 2009, 48,
2921; (b) J. H. Ryu, E. Lee, Y. Lim, M. Lee, J. Am. Chem. Soc.,
2007, 129, 4808; (c) B. S. Kim, D. J. Hong, J. Bae, M. Lee, J. Am.
Chem. Soc., 2005, 127, 16333; (d) B. S. Kim, W. Y. Yang, J. H. Ryu,
Y. S. Yoo, M. Lee, Chem. Commun., 2005, 2035.
This journal is © The Royal Society of Chemistry [year]
Journal Name, [year], [vol], 00–00 | 5